BNT152 / BioNTech - LARVOL DELTA

BNT152-01C: Dose Escalation Trial of BNT152+153 in Patients With Cancer (clinicaltrials.gov) - P1 | N=86 | Completed | Sponsor: BioNTech SE | Active, not recruiting ➔ Completed

First-in-human • Trial completion • Oncology • Solid Tumor

BNT152-01C: Dose Escalation Trial of BNT152+153 in Patients With Cancer (clinicaltrials.gov) - P1 | N=86 | Active, not recruiting | Sponsor: BioNTech SE | Recruiting ➔ Active, not recruiting | N=170 ➔ 86

Enrollment change • Enrollment closed • Oncology • Solid Tumor